Regeneron Pharmaceuticals Inc.
REGN | NASDAQ
$968.55
+$40.66 (+4.38%)
Nov 2, 2026, 12:44 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | 4.5B | 4.41B | 3.95B | 4.34B | 8.08B | 3.51B |
Depreciation & Amortization | 543.7M | 482.9M | 421M | 341.4M | 286.2M | 235.9M |
Stock-Based Compensation | 993.7M | 982.8M | 885M | 725M | 601.7M | 432M |
Other Working Capital | -427M | -179.7M | -82.2M | -116.2M | -360.9M | 263M |
Other Non-Cash Items | -810.6M | -82.2M | 266.3M | 599.8M | 181.7M | -135M |
Deferred Income Tax | -785.4M | -757.3M | -837.8M | -746.4M | -147.1M | 75.6M |
Change in Working Capital | 532.6M | -618.3M | -94.1M | -243.3M | -1.92B | -1.5B |
Operating Cash Flow | 4.98B | 4.42B | 4.59B | 5.01B | 7.08B | 2.62B |
Capital Expenditures | -898.4M | -755.9M | -926.4M | -590.1M | -551.9M | -614.6M |
Cash Acquisitions | -3.3M | -16.5M | -54.9M | -230.3M | 551.9M | 614.6M |
Purchase of Investments | -10.96B | -16.62B | -11.65B | -7.49B | -7.05B | -3.24B |
Sales Maturities Of Investments | 11.55B | 15.03B | 9.44B | 5.55B | 2.22B | 3.79B |
Other Investing Acitivies | n/a | -105.6M | n/a | -1.03B | -551.9M | -614.6M |
Investing Cash Flow | -629.1M | -2.47B | -3.19B | -3.78B | -5.38B | -70.6M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 1.98B |
Common Stock Repurchased | -3.97B | -3.63B | -2.24B | -2.53B | -2.68B | -6.53B |
Dividend Paid | -370.3M | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.3M | -33.4M | -700.6M | -445.7M | -1.03B | 2.58B |
Financial Cash Flow | -3.72B | -2.2B | -1.79B | -1.01B | -1.01B | -1.97B |
Net Cash Flow | 634.7M | -248.8M | -381.6M | 221.3M | 690.8M | 577M |
Free Cash Flow | 4.08B | 3.66B | 3.67B | 4.42B | 6.53B | 2B |
Adj. Free Cash Flow | 3.09B | 2.68B | 2.78B | 3.7B | 5.93B | 1.57B |
Maintenance CapEx | -853.25M | -409.7M | -619.32M | -590.1M | n/a | n/a |
Growth CapEx | -45.15M | -346.2M | -307.08M | n/a | -551.9M | -614.6M |
Owner Earnings | 4.13B | 4.01B | 3.97B | 4.42B | 7.08B | 2.62B |
Add to Watchlist
Select watchlists to add or remove REGN